Medical management of advanced gastric cancer
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 24 (2) , 113-118
- https://doi.org/10.1016/s0305-7372(98)90077-9
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancerAnnals of Oncology, 1997
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancerAnnals of Oncology, 1995
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995
- Initial or delayed chemotherapy with best supportive care in advanced gastric cancerAnnals of Oncology, 1994
- Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancerCancer, 1993
- Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sitesBritish Journal of Cancer, 1990
- Gastric cancer: A 25-year reviewBritish Journal of Surgery, 1989
- Continuous 5-Fluorouracil Infusion in Advanced Gastric CarcinomaAmerican Journal of Clinical Oncology, 1988
- Phase-II clinical trial of 4′-epi-doxorubicin in metastatic solid tumorsZeitschrift für Krebsforschung und Klinische Onkologie, 1983
- Adenocarcinoma of the stomach: Review of 1,497 casesCancer, 1978